Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID

NCT06974084 is registered in ClinicalTrials.gov with HealthBio, Inc. as lead sponsor.

NCT NCT06974084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06974084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Lead sponsor
HealthBio, Inc.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
May 31, 2027
Enrollment
252 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid